G Di Felice Selected Research

Interleukin-2 (IL2)

1/2000

Five-year survival results of subcutaneous low-dose immunotherapy with interleukin-2 alone in metastatic renal cell cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G Di Felice Research Topics

Disease

5	Hypersensitivity (Allergy) 03/2012 - 11/2002
2	Seasonal Allergic Rhinitis (Hay Fever) 03/2012 - 08/2001
2	Food Hypersensitivity (Food Allergy) 04/2011 - 02/2006
2	Asthma (Bronchial Asthma) 01/2007 - 04/2005
1	Anaphylaxis (Anaphylactic Shock) 04/2011
1	Allergic Rhinitis 01/2007
1	Rhinitis 04/2005
1	Milk Hypersensitivity (Milk Allergy) 05/2000
1	Disease Progression 01/2000
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2000
1	Neoplasms (Cancer) 01/2000

Drug/Important Bio-Agent (IBA)

6	AllergensIBA 03/2012 - 08/2001
3	Immunoglobulin E (IgE)IBA 04/2005 - 05/2000
2	AntibodiesIBA 03/2012 - 04/2005
1	TropomyosinIBA 04/2011
1	Histamine (Histamine Dihydrochloride)FDA Link 04/2011
1	CytokinesIBA 04/2011
1	Transcription Factors (Transcription Factor)IBA 04/2011
1	Proteins (Proteins, Gene)FDA Link 02/2006
1	Immunoglobulin G (IgG)IBA 03/2004
1	Interleukin-2 (IL2)IBA 01/2000

Therapy/Procedure

4	Immunotherapy 03/2012 - 01/2000
1	Oral Administration 04/2011
1	Intravenous Infusions 01/2000
1	Therapeutics 01/2000
1	Subcutaneous Injections 01/2000